Peter R. Przekop, Jr, Henry Tulgan, Allison A. Przekop, and Michael Glantz
J Am Osteopath Assoc 2006 106:706-707.
[Abstract]
[Full Text]
[PDF]
Many adverse drug reactions (ADRs) can be linked to single-nucleotide
polymorphisms in genes that control drug disposition. These natural variations
can dramatically alter the synthesis of proteins as they metabolize and
respond to introduced pharmacologic agents. The authors report a case in which
a standard dose of methotrexate, an antimetabolite, resulted in
life-threatening mucositis, neutropenia, and thrombocytopenia in a 61-year-old
woman. The emerging field of pharmacogenetics, which explores the contribution
of genetic differences to drug response, has provided insight into the origin
of many ADRs. These considerations are particularly important when drugs with
narrow therapeutic indices or those typically administered at or near their
maximum tolerated doses are prescribed.